CN Patent

CN103703000B — Cdk4/6和flt3的稠合三环双重抑制剂

Assigned to Amgen Inc · Expires 2015-11-25 · 10y expired

What this patent protects

式(I)化合物是有用的CDK4。CDK6和FLT3的抑制剂。此类化合物可用于治疗癌症和各种其它疾病症状。式(I)化合物具有下列结构: 其中R 1 是式(IA)、式(IB)、式(IC)、或式(ID)的基团 且本文提供了其它变量的定义。

USPTO Abstract

式(I)化合物是有用的CDK4。CDK6和FLT3的抑制剂。此类化合物可用于治疗癌症和各种其它疾病症状。式(I)化合物具有下列结构: 其中R 1 是式(IA)、式(IB)、式(IC)、或式(ID)的基团 且本文提供了其它变量的定义。

Drugs covered by this patent

Patent Metadata

Patent number
CN103703000B
Jurisdiction
CN
Classification
—
Expires
2015-11-25
Drug substance claim
No
Drug product claim
No
Assignee
Amgen Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.